AMD Alliance International Holds North American Meeting

Leaders from Across the Globe Gather to Share Ideas, Strategies to Prevent Vision Loss from Age-related Macular Degeneration

Ft. Worth, TEXAS (Feb. 2, 2012)– Representatives of leading vision health groups are converging on Ft. Worth, Texas, to participate in AMD Alliance International’s (AMDAI) North American meeting on Feb. 3 from 8 a.m.-3 p.m. at the Omni Fort Worth Hotel.  AMD Alliance International (AMDAI), a global consortium of more than 70 members in 25 countries, provides hope and help to people worldwide living with macular disease.

As part of the conference, the following scheduled presentations are:

  • Global Economic Cost of Visual Impairment Study- Keith D. Gordon, Vice President Research, CNIB
  •  AMDAI Scientific Advisory Panel Meeting Report- Alan Cruess, M.D., Chair of Ophthalmology, Dalhousie University Medical School
  •  International MD Support Group:  A Model for Successful Outreach- Dan Roberts, Director, MD Support

For those who are interested but unable to attend in person, AMDAI is offering a webinar free of charge.  Participants in the United States and Canada may dial (866) 740-1260 with the access code of 3906884.  Online, participants may go to https://cc.readytalk.com/r/49rnay8oh5cy.

Discussions will be held to share best practices of participating vision organizations, current advancements in AMD studies and drug therapies as well as new research findings and its impact on those living with AMD.

According to the National Eye Institute, more than 9 million Americans, ages 40 and older, have some form of AMD.  AMD slowly robs people of their central vision and, if left untreated, can result in severe vision loss and even blindness. There are two forms of AMD: "dry" and "wet". Dry AMD is the most common form of the disease. It involves the presence of drusen – fatty deposits that form under the light-sensing cells in the retina. Vision loss in dry AMD usually progresses slowly. Wet AMD is less common, but more rapidly threatening to vision. Wet AMD causes tiny blood vessels under the retina to leak or break open. This distorts vision and causes scar tissue to form.

“We are thrilled to have so many dedicated leaders in the mission of ending AMD coming together to address important issues and developments in the treatment and prevention of this debilitating eye disease,” said Narinder Sharma BSc.Hons., MBA, PGDL, and CEO of AMDAI. “It is our hope that after this conference, we will all be better armed to serve those who already suffer from one of the leading causes of blindness as well those who are at risk .”

For more information on AMD or AMDAI, please visit amdalliance.orgor e-mail info@amdalliance.org.

About AMDAI

AMD Alliance International strives to bring knowledge, help and hope to individuals and families around the world affected by AMD. Our mission is accomplished through:

  • Generating awareness and understanding of age-related macular degeneration;
  • Promoting the importance of education, early detection, knowledge of treatment and rehabilitation options; and.
  • Preserving vision and improving the quality of life of individuals affected by age-related macular degeneration.

Download a copy of the AMD Alliance International press release